News & Articles

Bio-Rad Laboratories has launched a range of anti-certolizumab pegol inhibitory antibodies to support the development of anti-drug antibody (ADA) assays

Designed with a porous glass membrane for transmigration and transport studies under both static and flow conditions

Discover the latest research applications using multiplex technology to maximize sample use, while saving time and money

From flow cytometry and kinetic analysis to porous membranes and liquid handling, find out the latest techniques and technologies advancing cell-based assays

Watch our on-demand webinar to learn how to expand your lab capabilities with this mass spectroscopy technology

The serology test promises 100% sensitivity and can help assess patients' immune response to the virus

Best practice to simulate realistic pipe conditions using a Rotating Cylinder Electrode

Join this upcoming webinar to understand how NMR-based metabolomics can provide important information at all stages of the cancer timeline

The molecular test kit promises 100% diagnostic sensitivity and specificity, and is authorized for clinical practice use in Europe

The antibody test, which has a potential time to result of 14 minutes, will join the rest of the company's diagnostic portfolio

Download this white paper from Sartorius to find out how advanced flow cytometry addresses the challenges and demands of modern drug discovery pipelines

Self-aligning, self-optimizing system helps keep the focus on results

OncoSpan range expanded to include FFPE and cfDNA formats to mimic solid tumors and liquid biopsy samples, respectively

The company aims to provide solutions for the pandemic through close collaboration with scientists and providing cutting-edge laboratory equipment

Learn more about how BINDER is helping countless laboratories across the world conduct research into coronavirus.

Collaboration will enable global development, manufacturing and distribution of the vaccine

These models aim to accelerate treatment development prior to clinical trials

The test will be available for qualified laboratories across the European Union by the end of May